Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Heying Jianpi Lishui Decoction is a Traditional Chinese Medicine (TCM) herbal formulation developed by LongHua Hospital, affiliated with the Shanghai University of Traditional Chinese Medicine. It is specifically designed for the treatment of diabetic macular edema (DME). The decoction's therapeutic rationale is rooted in TCM theory, focusing on harmonizing the nutritive level (Ying), tonifying the spleen (Jianpi), and resolving fluid accumulation (Lishui). It is being evaluated in clinical trials to assess its efficacy in improving visual acuity and reducing macular thickness, either as a monotherapy or in combination with standard treatments like anti-VEGF injections or calcium dobesilate.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on heying jianpi lishui decoction.